Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Open Forum Infectious Diseases
|
January 29, 2021
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees
Karina Oganezova, Elvin J Fontana-Martinez, Jon A Gothing, et al.
The Journal of Infectious Diseases
|
November 6, 2012
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)
Dan H Barouch, Jinyan Liu, Lauren Peter, et al.
The Journal of Infectious Diseases
|
April 11, 2014
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
The Journal of Infectious Diseases
|
November 6, 2012
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Plos One
|
August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)
Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
The Journal of Infectious Diseases
|
August 29, 2014
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans
Lindsey R Baden, Jinyan Liu, Hualin Li, et al.
Annals of Internal Medicine
|
February 3, 2016
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial
Lindsey R Baden, Etienne Karita, Gaudensia Mutua, et al.
Vaccine
|
May 31, 2011
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
Dan H Barouch, Sandra V Kik, Gerrit J Weverling, et al.
The Journal of Infectious Diseases
|
April 19, 2018
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Open Forum Infectious Diseases
|
January 29, 2021
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees
Karina Oganezova, Elvin J Fontana-Martinez, Jon A Gothing, et al.
The Journal of Infectious Diseases
|
November 6, 2012
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)
Dan H Barouch, Jinyan Liu, Lauren Peter, et al.
The Journal of Infectious Diseases
|
April 11, 2014
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
The Journal of Infectious Diseases
|
November 6, 2012
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Plos One
|
August 23, 2011
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)
Gavin J Churchyard, Cecilia Morgan, Elizabeth Adams, et al.
The Journal of Infectious Diseases
|
August 29, 2014
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans
Lindsey R Baden, Jinyan Liu, Hualin Li, et al.
Annals of Internal Medicine
|
February 3, 2016
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial
Lindsey R Baden, Etienne Karita, Gaudensia Mutua, et al.
Vaccine
|
May 31, 2011
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
Dan H Barouch, Sandra V Kik, Gerrit J Weverling, et al.
The Journal of Infectious Diseases
|
April 19, 2018
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Page
of 3